Download now Free registration required
Inc pharmaceutical Industry has enjoyed a protracted winning streak in which it has scored a decade of tremendous growth and profits on the back of novel and important medicines. But where will the victories come from in the next ten years? The pharma industry has entered a period of significant uncertainty and transition, characterized so far by higher R&D costs and fewer new drugs against a backdrop of calls for price controls and access restriction as society reaches the limits of willingness and ability to pay for pharmaceutical innovation.
- Format: PDF
- Size: 94.7 KB